title: [Hematopoietic stem cell transplantation for malignant lymphoma].
abstract: Autologous peripheral blood stem cell transplantation (auto-PBSCT) is increasingly performed as a curative therapy for patients with malignant lymphoma. Aggressive lymphomas which have relapsed with chemo-sensitive state, and newly diagnosed cases with high risk prognostic factors are good candidates for auto-PBSCT. Clinical results and indications for hematopoietic stem cell transplantation, including other types of lymphoma, are reviewed in this paper.
authors.affiliation: Department of Hematology and Chemotherapy, Aichi Cancer Center, Nagoya, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Morishima
mesh_terms: D002986:Clinical Trials as Topic; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate